Integra LifeSciences (NSDQ:IART) yesterday raised its long-term forecast out to 2018, saying it expects to post higher numbers across the board. The new outlook calls for adjusted earnings-per-share growth of 12% or more, up from 10% previously, on organic sales growth of 6% to 8%, up from prior guidance of 5% to 7%. Gross margins […]
Wound Care
Derma Sciences scraps trial, mulls sale
Derma Sciences (NSDQ:DSCI) said today it would evaluate all options, including a sale, after scrapping a trial of its aclerastide drug for diabetic foot ulcers. DSCI shares plunged as much as 31%, dropping under their 6-year low today. The company makes wound care and regenerative medicine products. Aclerastide was its only drug candidate. Princeton, N.J.-based Derma Sciences said […]
Acelity says IPO could fetch up to $1B
Wound care and regenerative medicine company Acelity yesterday said it expects to raise as much as $1 billion in its forthcoming initial public offering as it looks for a way to pay down its debt. Acelity, formerly Kinetic Concepts Inc., was acquired for $6.1 billion by Apax Partners and a pair of Canadian pension funds in a […]
BSN Medical picks up lymphoedema focused JoViPak
BSN Medical said yesterday it purchased lymphoedema garment manufacturer JoViPak. Seattle-based JoViPak produced lymphoedema management garments for the treatment of both acute and chronic oedema, according to BSN Medical. The companies did not disclose details of the transaction. “Being afflicted with lymphoedema myself, I created JoViPak out of compassion for and an understanding of patients. […]
Acelity registers for IPO that could fetch $1B
Wound care and regenerative medicine company Acelity registered for an initial public offering today that could raise as much as $1 billion, confirming rumors that 1st surfaced in June that its private equity owners are looking look to pay down debt. Acelity, formerly Kinetic Concepts Inc., was acquired for $6.1 billion by Apax Partners and a […]
Acelity announced Q2 earnings, beats 2014
Wound care and regenerative medicine company Acelity reported its Q2 earnings this week, beating its revenue and sales marks the same quarter last year. The San Antonio, Texas-based company said it brought in $461.6 million this quarter, beating last year’s revenue by a meager 0.5%. The company significantly pared losses, bringing them down to $17.6 […]
Acelity wins VA contract for NPWT
Acelity said Wednesday it won a 5-year National Blanket Purchase Agreement with the Department of Veterans Affairs to supply it with negative pressure wound therapy supplies and devices. Through the deal, San Antonio, Texas-based Acelity will supply the VA with devices that help promote wound healing for acute and chronic wounds. “Deep wounds caused by […]
Integra LifeSciences closes $312m TEI buyout
Integra LifeSciences (NSDQ:IART) said today that it closed its $312 million acquisition of TEI Biosciences and sister company TEI Medical, expanding its footprint in reconstructive surgery and regenerative wound care. The deal brings TEI’s PriMatrix dermal repair scaffold and a 125-member sales force under the Integra umbrella, that Plainsboro, N.J.-based company said. TEI is based in Waltham, Mass. […]
Appeals court overturns KCI win in whistleblower case
A federal appeals court this week overturned the dismissal of a lawsuit filed against Kinetic Concepts Inc. (now Acelity), in the process resetting the precedent used to establish standing in whistleblower lawsuits. The U.S. Court of Appeals for the 9th Circuit cut 1 of the 3 prongs for establishing a qui tam whistleblower case, ruling that whistleblowers […]
HemCon enters Chinese wound care market
HemCon Medical Technologies gained Chinese regulatory approval to start selling wound care products in the world’s largest nation.